151 related articles for article (PubMed ID: 15841692)
1. Cyclin-dependent kinase (cdk6) and p16 in pancreatic endocrine neoplasms.
Tomita T
Pathology; 2004 Dec; 36(6):566-70. PubMed ID: 15841692
[TBL] [Abstract][Full Text] [Related]
2. Amylin in pancreatic islets and pancreatic endocrine neoplasms.
Tomita T
Pathol Int; 2003 Sep; 53(9):591-5. PubMed ID: 14507315
[TBL] [Abstract][Full Text] [Related]
3. Neuropilin-2 is a novel marker expressed in pancreatic islet cells and endocrine pancreatic tumours.
Cohen T; Herzog Y; Brodzky A; Greenson JK; Eldar S; Gluzman-Poltorak Z; Neufeld G; Resnick MB
J Pathol; 2002 Sep; 198(1):77-82. PubMed ID: 12210066
[TBL] [Abstract][Full Text] [Related]
4. Expression of vascular endothelial growth factor in digestive neuroendocrine tumours.
Terris B; Scoazec JY; Rubbia L; Bregeaud L; Pepper MS; Ruszniewski P; Belghiti J; Fléjou J; Degott C
Histopathology; 1998 Feb; 32(2):133-8. PubMed ID: 9543669
[TBL] [Abstract][Full Text] [Related]
5. Lymphatic vessel endothelial hyaluronan receptor 1 immunocytochemical staining for pancreatic islets and pancreatic endocrine tumors.
Tomita T
Pancreas; 2007 Nov; 35(4):e18-22. PubMed ID: 18090227
[TBL] [Abstract][Full Text] [Related]
6. Immunocytochemical staining for islet amyloid polypeptide in pancreatic endocrine tumors.
Tomita T
Islets; 2011; 3(6):344-51. PubMed ID: 21983096
[TBL] [Abstract][Full Text] [Related]
7. p27: a potential main inhibitor of cell proliferation in digestive endocrine tumors but not a marker of benign behavior.
Canavese G; Azzoni C; Pizzi S; Corleto VD; Pasquali C; Davoli C; Crafa P; Delle Fave G; Bordi C
Hum Pathol; 2001 Oct; 32(10):1094-101. PubMed ID: 11679944
[TBL] [Abstract][Full Text] [Related]
8. Cleaved caspase-3 immunocytochemical staining for pancreatic islets and pancreatic endocrine tumors: A potential marker for biological malignancy.
Tomita T
Islets; 2010; 2(2):82-8. PubMed ID: 21099299
[TBL] [Abstract][Full Text] [Related]
9. Activating point mutations in cyclin-dependent kinase 4 are not seen in sporadic pituitary adenomas, insulinomas or Leydig cell tumours.
Vax VV; Bibi R; Diaz-Cano S; Gueorguiev M; Kola B; Borboli N; Bressac-de Paillerets B; Walker GJ; Dedov II; Grossman AB; Korbonits M
J Endocrinol; 2003 Aug; 178(2):301-10. PubMed ID: 12904177
[TBL] [Abstract][Full Text] [Related]
10. Studies on co-localization of 7B2 and pancreatic hormones in normal and tumoural islet cells.
Azzoni C; Yu JY; Baggi MT; D'Adda T; Timson C; Polak JM; Bordi C
Virchows Arch A Pathol Anat Histopathol; 1992; 421(6):457-66. PubMed ID: 1466150
[TBL] [Abstract][Full Text] [Related]
11. PGP 9.5 immunocytochemical staining for pancreatic endocrine tumors.
Tomita T
Islets; 2013; 5(3):122-8. PubMed ID: 23959334
[TBL] [Abstract][Full Text] [Related]
12. Metallothionein in pancreatic endocrine neoplasms.
Tomita T
Mod Pathol; 2000 Apr; 13(4):389-95. PubMed ID: 10786804
[TBL] [Abstract][Full Text] [Related]
13. Prognostic and biological significance of cytokeratin 19 in pancreatic endocrine tumours.
La Rosa S; Rigoli E; Uccella S; Novario R; Capella C
Histopathology; 2007 Apr; 50(5):597-606. PubMed ID: 17394496
[TBL] [Abstract][Full Text] [Related]
14. [The pathology of insulinoma and gastrinoma. The location, size, multicentricity, association with multiple endocrine type-I neoplasms and malignancy].
Donow C; Pipeleers-Marichal M; Stamm B; Heitz PU; Klöppel G
Dtsch Med Wochenschr; 1990 Sep; 115(37):1386-91. PubMed ID: 1976084
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic polypeptide in islet cell tumors. Morphologic and functional correlations.
Tomita T; Kimmel JR; Friesen SR; Doull V; Pollock HG
Cancer; 1985 Oct; 56(7):1649-57. PubMed ID: 2992743
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical localization of human kallikreins 6 and 10 in pancreatic islets.
Petraki CD; Karavana VN; Revelos KI; Luo LY; Diamandis EP
Histochem J; 2002; 34(6-7):313-22. PubMed ID: 12769263
[TBL] [Abstract][Full Text] [Related]
17. Gelatinases and inhibitors of gelatinases in pancreatic islets and islet cell tumors.
Tomita T; Iwata K
Mod Pathol; 1997 Jan; 10(1):47-54. PubMed ID: 9021726
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic endocrine tumour: a 22-year clinico-pathological experience with morphological, immunohistochemical observation and a review of the literature.
Lam KY; Lo CY
Eur J Surg Oncol; 1997 Feb; 23(1):36-42. PubMed ID: 9066745
[TBL] [Abstract][Full Text] [Related]
19. Anatomic distribution of pancreatic endocrine tumors.
Howard TJ; Stabile BE; Zinner MJ; Chang S; Bhagavan BS; Passaro E
Am J Surg; 1990 Feb; 159(2):258-64. PubMed ID: 2154144
[TBL] [Abstract][Full Text] [Related]
20. Multihormonality and entrapment of islets in pancreatic endocrine tumors.
Kapran Y; Bauersfeld J; Anlauf M; Sipos B; Klöppel G
Virchows Arch; 2006 Apr; 448(4):394-8. PubMed ID: 16418841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
